Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

ClinicalTrials.gov ID: NCT00003563

Public ClinicalTrials.gov record NCT00003563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Randomized Trial of Gadolinium Texaphyrin (PCI-0120) Injection as a Radiation Sensitizer in Patients Receiving Whole Brain Radiation Therapy for the Treatment of Brain Metastases

Study identification

NCT ID
NCT00003563
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pharmacyclics LLC.
Industry
Enrollment
430 participants

Conditions and interventions

Interventions

  • WBRT Radiation
  • MGd Drug

Radiation · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 1998
Primary completion
Aug 31, 2001
Completion
May 31, 2005
Last update posted
Oct 30, 2013

1998 – 2005

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Marin Oncology Associates, Inc. Greenbrae California 94904
Kaiser Permanente Medical Group Los Angeles California 90027
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Beckman Research Institute, City of Hope Los Angeles California 91010
Radiation Oncology Center - Sacramento Sacramento California 95816
University of Colorado Cancer Center Denver Colorado 80262
Charlotte County Radiation Therapy Regional Center Port Charlotte Florida 33952
Emory Clinic Atlanta Georgia 30365
Indiana University Cancer Center Indianapolis Indiana 46202-5265
Hematology and Oncology Services - Metairie Metairie Louisiana 70006
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201
Harper Hospital and Wayne State University Detroit Michigan 48201
Veterans Affairs Medical Center - Minneapolis Minneapolis Minnesota 55417
North Memorial Research Center Minneapolis Minnesota 55442-2900
Cancer Institute of New Jersey New Brunswick New Jersey 08901
New Mexico Oncology-Hematology Albuquerque New Mexico 87102
Memorial Sloan-Kettering Cancer Center New York New York 10021
Barrett Cancer Center, The University Hospital Cincinnati Ohio 45219
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Abington Hematology Oncology Associates Meadowbrook Pennsylvania 18974
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107
Presbyterian-University Hospital Pittsburgh Pennsylvania 15213
Mercy Hospital Cancer Center - Scranton Scranton Pennsylvania 18501
Thompson Cancer Survival Center Knoxville Tennessee 37916
Vanderbilt Cancer Center Nashville Tennessee 37232-6838
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009
Scott and White Memorial Hospital Temple Texas 76508
Virginia Mason Medical Center Seattle Washington 98111
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2013 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →